Safety and efficacy of dacomitinib in Korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: A phase I/II trial

Keunchil Park, Byoung C. Cho, Dong Wan Kim, Myung Ju Ahn, Sang Yoon Lee, Diana Gernhardt, Ian Taylor, Alicyn K. Campbell, Hui Zhang, Nagdeep Giri, Stephen P. Letrent, Joseph O'Connell, Dae S. Heo

Research output: Contribution to journalArticle

16 Citations (Scopus)

Fingerprint Dive into the research topics of 'Safety and efficacy of dacomitinib in Korean patients with KRAS wild-type advanced non-small-cell lung cancer refractory to chemotherapy and erlotinib or gefitinib: A phase I/II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences